Additionally, the “ErbB Signaling Pathway,” “Tight Junction,” “Glioma,” and “Small Cell Lung Cancer” pathways are also prominently represented, further highlighting the broad regulatory impact of NFIA, NFIB, NFIC, and NFIX on several types of cancer (Fig. 4, E and F). This evidence concerns the gene NFIB and small cell lung carcinoma.